DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
This is unchanged from the number of companies inspected in the previous year.
Most of the companies inspected were involved in the Biologics sector. The second most common type of company inspected in the time period worked in the Food/Cosmetics sector.
There were seven companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
CellMark USA, LLC | Food/Cosmetics | 05/10/2023 | No Action Indicated (NAI) |
Eb Passos, LLC | Food/Cosmetics | 04/27/2023 | Voluntary Action Indicated (VAI) |
NutriScience Innovations, LLC | Food/Cosmetics | 08/07/2023 | No Action Indicated (NAI) |
Protein Sciences Corporation | Biologics | 05/01/2023 | No Action Indicated (NAI) |
Reproductive Endocrine Center Sperm Physiology Lab | Biologics | 06/08/2023 | No Action Indicated (NAI) |
Stelray Plastic Products, Inc. | Devices | 12/21/2023 | No Action Indicated (NAI) |
Susann Varano, M.D. | Biologics | 05/26/2023 | No Action Indicated (NAI) |
Yale Center For Reproductive Medicine & Infertility | Biologics | 08/28/2023 | No Action Indicated (NAI) |